A Post-Marketing Clinical Study of LY450190 (Combined With Alpha1 Blocker Treatment)
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 19 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 05 May 2015 New trial record